Home›Stock Screener›Medicamen Organics

Medicamen Organics Share Price Today | Stock Price & Medicamen Organics Share Screener

MEDIORG Pharmaceuticals

Track the current Medicamen Organics share price and stock price live with TickJournal's free stock screener. Check Medicamen Organics 52-week for the annual price range and momentum. Use the Medicamen Organics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medicamen Organics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Medicamen Organics Market Cap ₹35.79 Cr.
MEDIORG P/E Ratio (TTM) -
Medicamen Organics P/B Ratio 0.94
EPS (TTM) ₹-3.41
Dividend Yield -
Debt to Equity 0.45
MEDIORG 52 Week High -
Medicamen Organics 52 Week Low -
Operating Margin -
Profit Margin -
MEDIORG Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹52.00
Total Equity ₹29.00

Medicamen Organics Share Price Chart

Track the current stock price of Medicamen Organics with an interactive chart. Analyse MEDIORG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medicamen Organics stock quote in one place.

Medicamen Organics Company Profile - Fundamental Screener

Screen Medicamen Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDIORG shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0PE401018.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0PE401018

Medicamen Organics Balance Sheet Screener

Screen MEDIORG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹52, down from ₹59 in 2025.

Latest statistics put total assets at ₹52 and shareholder funds at ₹29, with a leverage ratio of 0.45.

Item 2026 2025 2024

Assets

Total Assets 52 59 38
Current Assets 37 45 27
Fixed Assets 13 10 10

Liabilities

Total Liabilities 0 0 0
Current Liabilities 1 2 2
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 29 31 15
Share Capital 12 12 9
Reserves & Surplus 17 18 7

Medicamen Organics Income Statement Screener - Profit & Revenue Analysis

Screen Medicamen Organics income statement and profit fundamentals. Analyze MEDIORG quarterly results. Medicamen Organics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹23 and net profit of ₹-4.

Item None-None 2026-March 2025-March 2024-March

Revenue and Expenses

Revenue 0 23 38 25
Expenses 0 26 32 21

Operating Costs and Margins

EBITDA 0 -4 7 5
Operating Profit % 0.00% -17.00% 17.00% 19.00%
Depreciation 0 1 1 1
Interest 0 1 1 1

Profit and Earnings

Profit Before Tax 0 -5 5 4
Tax 0 -1 1 2
Net Profit 0 -4 4 3
EPS 0.00 -3.41 3.67 3.47

Medicamen Organics Cash Flow Screener - Liquidity Fundamentals

Screen MEDIORG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹5, and net cash flow was an outflow of ₹3.

Over the same period, investing activities used ₹2 and financing activities provided ₹4.

Item 2026-March 2025-March 2024-March

Cash from Operations and Investing

Operating Activities -5 -5 -4
Investing Activities -2 -2 0

Financing and Net Cash

Financing Activities 4 11 4
Net Cash Flow -3 4 0

Medicamen Organics Shareholding Pattern Screener

See Medicamen Organics shareholding pattern with promoter, FII, and DII holdings. Check Medicamen Organics promoter holding and ownership changes for MEDIORG on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 54.89%, foreign institutions 0.05%, domestic institutions 0.00% and the public 24.17%, spread across 508 shareholders.

The shareholder count was 508 in 2026-Jun, compared with 540 in 2026-Mar.

Item 2026-Jun 2026-Mar 2026-Jan 2025-Sept 2025-Mar 2024-Sept 2024-Jun 2024-Feb

Promoter Holding

Promoter Holding 54.89% 59.73% 61.27% 59.73% 59.73% 59.69% 59.69% 81.21%

Institutional Investors

FII Holding 0.05% 0.07% 0.07% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 1.64% 3.55% 0.00% 0.10% 0.07% 0.27% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 24.17% 30.79% 28.75% 30.58% 28.79% 28.27% 13.85% 0.00%
Other Holding 20.89% 7.78% 6.36% 9.69% 11.38% 11.97% 26.19% 18.79%
Shareholder Count 508 540 515 507 460 379 34 34

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medicamen Organics. Medicamen Organics dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Medicamen Organics.

Medicamen Organics Stock Index Membership - Nifty & Sensex

See which indices include Medicamen Organics stock. Check MEDIORG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Medicamen Organics is not part of any tracked indices.
Only major market indices are tracked in our system.

Medicamen Organics Market Events Screener - Corporate Actions

Get Medicamen Organics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medicamen Organics stock events that may affect MEDIORG share price, along with derivatives, futures and options activity and sector gainers.

6 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 29, 2026, with a record date of May 29, 2026.

It is followed by Extraordinary General Meeting dated April 9, 2026 and Quarterly Result Announcement dated November 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-05-29 2026-05-29 Quarterly Result Announcement NA -1.64%
2026-04-09 2026-04-09 Extraordinary General Meeting NA 27.27%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -6.98%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 15.46%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 1.32%
2024-09-27 2024-09-27 Annual General Meeting NA -5.45%

Medicamen Organics Competitors Screener - Peer Stocks Comparison

Screen MEDIORG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 435,863 36.83 61,674 12.69% 11,565 38.95
Divis Laboratories 246,660 86.00 11,067 13.95% 2,568 53.27
Torrent Pharmaceuticals 182,577 86.72 13,886 20.34% 2,138 42.82
Zydus Life Science 115,910 25.96 27,658 17.64% 5,026 51.33
Cipla 108,738 33.29 29,045 2.24% 3,870 35.23
Laurus Labs 106,982 98.39 6,868 22.01% 890 58.13
Mankind Pharma 103,418 50.84 14,636 14.85% 1,938 59.40
Dr Reddys Laboratories 102,916 32.77 35,059 3.90% 4,158 62.37
Aurobindo Pharma 96,203 26.41 34,145 5.56% 3,503 49.32
Lupin 92,839 16.97 29,039 26.75% 5,356 31.32

Medicamen Organics Company Announcements - News & Reports Screener

Screen MEDIORG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 0.94. Market capitalisation stands at ₹35.79 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 6, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.